Common use of Royalty Payment Period Clause in Contracts

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:

Appears in 8 contracts

Samples: Option and License Agreement, Option and License Agreement (Ultragenyx Pharmaceutical Inc.), Option and License Agreement (Dimension Therapeutics, Inc.)

AutoNDA by SimpleDocs

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 on the Net Sales of Licensed Products in a given country will end on a country-by-country basisbasis when all Valid Claims in that country claiming the Licensed Product have expired, as follows:lapsed, been abandoned, or been invalidated.

Appears in 4 contracts

Samples: License Agreement (Audentes Therapeutics, Inc.), License Agreement (Audentes Therapeutics, Inc.), License Agreement (REGENXBIO Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:basis when ****.

Appears in 3 contracts

Samples: License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 3.3 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:basis […***…].

Appears in 3 contracts

Samples: License Agreement (Ultragenyx Pharmaceutical Inc.), License Agreement (Dimension Therapeutics, Inc.), License Agreement (Dimension Therapeutics, Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:basis when the Licensed Product ceases to infringe or be covered by a Valid Claim in that country.

Appears in 3 contracts

Samples: License Agreement (AveXis, Inc.), License Agreement (AveXis, Inc.), License Agreement (REGENXBIO Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 on the Net Sales of Licensed Products in a given country will end on a country-by-country basiscountry, as follows:Licensed Product-by-Licensed Product basis on the later of: (i) expiration, lapse, abandonment, or invalidation of the last Valid Claim of the Licensed Patents to expire, lapse, become abandoned or become unenforceable for the applicable Licensed Product in the applicable country, or (ii) **** from the First Commercial Sale of the applicable Licensed Product in the applicable country.

Appears in 2 contracts

Samples: License Agreement (Abeona Therapeutics Inc.), License Agreement (REGENXBIO Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 3.3 on the Net Sales of Licensed Products in a given country will end on a country-by-country basisbasis when all Valid Claims in that country claiming the Licensed Product have expired, as follows:lapsed, been abandoned, or been invalidated.

Appears in 2 contracts

Samples: License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)

AutoNDA by SimpleDocs

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 3.3.1 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:by country basis when there is no Valid Claim in that country claiming the Licensed Product.

Appears in 1 contract

Samples: Confidential Treatment Requested Agreement (REGENXBIO Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 3.3.1 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:by country basis when ****.

Appears in 1 contract

Samples: Confidential Treatment Requested Agreement (REGENXBIO Inc.)

Royalty Payment Period. Licensee’s obligation hereunder for payment of a royalty under this Section 3.4 3.3 on the Net Sales of Licensed Products in a given country will end on a country-by-country basis, as follows:basis ****.

Appears in 1 contract

Samples: License Agreement (REGENXBIO Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.